NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Ginkgo & OpenAI Slash Protein Synthesis Costs by 40%

Ginkgo Bioworks teams up with OpenAI to cut cell-free protein synthesis costs by 40% using AI and cloud lab automation.

Ginkgo & OpenAI Slash Protein Synthesis Costs by 40%
Credit: Chona Kasinger/Bloomberg via Getty Images
Already have an account? Sign in.
Featured/ 02/05/2026 · 3:28 PM
DNA
/ Don’t stop at just one post.

Related↓

Ginkgo Bioworks and Bayer Extend Partnership to Advance Sustainable Agriculture
10/31/2025 · 11:15 AM

Ginkgo Bioworks and Bayer Extend Partnership to Advance Sustainable Agriculture

Ginkgo Bioworks extends its multi-year collaboration with Bayer to develop next-generation biological products for agriculture, focusing on nitrogen fixation and sustainable farming.

/ Subscriber only
/ Read more

Feed↓

BofA Downgrades Biohaven to Underperform, Cuts Price Target to $11 on Kv7 Risks
Featured/ 06/29/2026 · 10:31 AM

BofA Downgrades Biohaven to Underperform, Cuts Price Target to $11 on Kv7 Risks

Analyst highlights competition risk in Kv7 epilepsy program and cuts peak sales forecast.

/ Subscriber only
Evommune’s EVO756 Fails Phase 2b Trial in Chronic Spontaneous Urticaria, Development Discontinued
Featured/ 06/29/2026 · 10:04 AM

Evommune’s EVO756 Fails Phase 2b Trial in Chronic Spontaneous Urticaria, Development Discontinued

Evommune reported EVO756 failed to meet its primary endpoint in the Phase 2b CSU trial. The company is discontinuing development in urticaria but advancing the drug in atopic dermatitis with data expected in Q3 2026.

/ Subscriber only
Martin Marietta Buys Lhoist North America for $13.5 Billion in Cash and Stock
Featured/ 06/29/2026 · 9:31 AM

Martin Marietta Buys Lhoist North America for $13.5 Billion in Cash and Stock

The acquisition adds over 2 billion tons of limestone reserves and creates $85M in annual synergies.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe